Sale!

Dostinex (Cabergoline)

A$96.04

-28%
Dostinex (cabergoline) is a medicine used to treat certain hormone-related conditions. It helps lower high levels of prolactin and may be prescribed for problems such as galactorrhoea (breast milk leakage) and fertility-related issues. Dostinex works by affecting brain signals that control prolactin release. Your prescriber will advise how to take it and how often. If you experience dizziness, nausea, or unusual sleepiness, seek medical advice.

Dostinex (Cabergoline) – Patient Guide (Australia)

Dostinex is a brand of cabergoline, a medicine used to treat hormone-related conditions, most commonly high prolactin levels (hyperprolactinaemia). It works by affecting dopamine receptors in the brain and can reduce prolactin production. This guide explains how Dostinex works, how it’s taken, what to expect, and key safety information to help you use it confidently in Australia.

This information is designed to be patient-friendly and educational. Always follow the dosing instructions provided by your healthcare professional and the product label.


Basic Product Information

Item Details
Brand name Dostinex
Generic name Cabergoline
Medicine type Dopamine receptor agonist (primarily D2)
Common form Tablets
Key action Reduces prolactin secretion and (in appropriate conditions) decreases tumour size
Common dosing schedule Often taken 1–2 times per week for hyperprolactinaemia (individual schedules vary)

How Dostinex Works (Mechanism of Action)

Cabergoline is a dopamine agonist. Dopamine is a neurotransmitter that helps regulate hormone release. In the pituitary gland, dopamine reduces prolactin secretion.

  • Stimulates dopamine (D2) receptors on lactotroph cells.
  • Decreases prolactin production and can lower prolactin levels in blood.
  • In some settings, reduces the size of prolactin-secreting pituitary tumours (where applicable).

Because prolactin levels may take time to normalise, improvements in symptoms (such as breast milk production, irregular periods, or sexual side effects) can occur gradually over weeks to months.


Pharmacokinetics (How the Body Processes Cabergoline)

Pharmacokinetics describes how the medicine is absorbed, distributed, metabolised, and eliminated. Cabergoline has characteristics that support dosing less frequently than many other prolactin-lowering agents.

  • Absorption: After oral dosing, cabergoline is absorbed from the gastrointestinal tract.
  • Distribution: It is distributed throughout the body and can cross into relevant tissues.
  • Metabolism: Cabergoline is metabolised primarily by liver pathways.
  • Elimination: It has a long duration of action, supporting less frequent dosing.
  • Half-life: The terminal half-life is long (supporting weekly or twice-weekly regimens in many patients).

Individual responses vary, and dose adjustments may be needed based on prolactin levels, symptoms, and tolerability. Your clinician may monitor prolactin and other relevant tests.


Typical Use and Timing

What it’s used for

Dostinex/cabergoline is used to treat conditions associated with elevated prolactin. The most common uses include:

  • Hyperprolactinaemia due to pituitary adenomas (prolactin-secreting tumours), where appropriate.
  • High prolactin with symptoms such as menstrual irregularities, infertility, galactorrhoea (unwanted milk discharge), or sexual dysfunction.
  • Other prolactin-related hormone disorders when cabergoline is indicated by your healthcare professional.

When to take it

Cabergoline is commonly taken in divided weekly doses, for example once or twice per week, depending on the prescribed regimen. The most important rule is to take doses consistently and as directed.

  • Choose a regular schedule: Many people take a dose on the same day(s) each week.
  • If your schedule changes: Discuss changes with your prescriber to avoid uneven dosing.
  • Waiting for results: Prolactin levels and symptom relief may take time.

Practical tip: Use a calendar or medication reminder to track weekly dosing. Missing doses can delay prolactin normalisation.


Food Interactions

Many patients wonder whether they should take cabergoline with food. In general, it may be taken with or without food; however, individual product guidance can vary. If you experience stomach upset, taking it with food may help.

  • Food effects: Food may influence absorption for some medicines; for cabergoline, timing relative to meals is often not critical.
  • Stomach side effects: Nausea or dizziness may occur; taking with a light meal can improve comfort.
  • Alcohol at the same time as meals: Alcohol can worsen dizziness and sedation—see the alcohol section below.

If you’re unsure about the best approach for your specific regimen, ask your pharmacist for advice based on your local product information.


Alcohol Interactions

Cabergoline can cause side effects such as dizziness, light-headedness, or sleepiness. Alcohol can intensify these effects.

  • Limit alcohol: Avoid or minimise alcohol during the first days of treatment or after any dose increase.
  • Plan for driving: If alcohol makes you drowsy or dizzy, don’t drive or operate machinery.
  • Safety first: Combine only if you know how you respond to the medicine.

If you have concerns about alcohol use (for example, regular heavy drinking), discuss this with a healthcare professional before starting or continuing Dostinex.


Medicine Interactions (Including Common Categories)

Cabergoline may interact with other medicines that affect blood pressure, alertness, or liver metabolism. Tell your pharmacist or healthcare professional about all medicines and supplements you use, including herbal products.

Potential interaction areas

  • Blood pressure–lowering medicines: Cabergoline can lower blood pressure. Combining with antihypertensives may increase risk of dizziness or fainting.
  • Medicines that cause drowsiness: Sedatives, sleep medicines, and some antihistamines may increase sedation.
  • Levodopa and other dopamine-related therapies: These may influence the effect of cabergoline.
  • Antipsychotics: Some antipsychotics can oppose dopamine agonists, potentially reducing cabergoline effectiveness.
  • Meds affecting the liver: Because cabergoline is metabolised in the liver, strong liver enzyme interactions could alter levels.

What to do

  • Keep an updated list of your medicines.
  • Ask whether any of your medications could worsen dizziness, low blood pressure, or sedation.
  • Do not start new medicines (including “natural” supplements) without checking interactions.

If you experience fainting, severe dizziness, or unusual sleepiness, seek medical advice promptly.


Indications (When Dostinex is Used)

Dostinex is prescribed for prolactin-related conditions. While the exact indication depends on diagnosis and test results, common indications include:

  • Hyperprolactinaemia due to pituitary adenoma and other causes.
  • Prolactin-related reproductive endocrine disorders where prolactin reduction is beneficial.
  • Galactorrhoea associated with elevated prolactin.

Your clinician may also consider whether cabergoline is appropriate based on MRI findings, hormone tests, and symptom patterns. Treatment may be long-term in some cases, and monitoring is part of routine care.


Dosing (General Guidance)

Dosage depends on the condition being treated, your prolactin level, symptoms, age, and how you tolerate cabergoline. The most accurate dosing information is the regimen provided for you.

Common dosing principles

  • Start low, go slow: Many patients begin on a lower dose to reduce side effects, then gradually increase if needed.
  • Weekly dosing: Cabergoline is often given once or twice weekly for hyperprolactinaemia.
  • Individualise: Some people need dose adjustments to reach prolactin goals.

Example of schedule types (not a prescription)

  • Once per week: A weekly dose taken on a chosen day.
  • Twice per week: Split into two doses separated by a few days to reduce fluctuations and improve tolerance.

Missed dose advice (general)

Because cabergoline dosing is often weekly, missed-dose instructions can vary by regimen. In general:

  • If you realise you missed a dose, contact your pharmacist or clinician for advice on what to do next.
  • Do not take a double dose unless instructed.

Safety Profile (What to Watch For)

Most people tolerate Dostinex/cabergoline reasonably well, but side effects can occur—especially during the first weeks or after dose increases. Report severe or persistent symptoms promptly.

Common side effects

  • Nausea
  • Headache
  • Dizziness or light-headedness
  • Fatigue or sleepiness
  • Low blood pressure (in some people)

Less common but important risks

  • Fainting or significant dizziness—particularly on standing.
  • Behavioural or impulse-control changes (rare, but important with dopamine agonists).
  • New or worsening sleepiness or sudden sleep episodes.
  • Heart valve issues (risk may be more relevant at higher or long-term doses; monitoring may be considered by your healthcare team).

Seek urgent help if

  • You faint or have severe dizziness.
  • You develop chest pain, shortness of breath, or palpitations.
  • You experience severe allergic symptoms (swelling of face/lips, breathing difficulty, widespread rash).

Who needs extra caution

  • People with low baseline blood pressure or history of fainting.
  • People with cardiac valve disease or significant heart problems.
  • People who drive or operate machinery and are prone to dizziness or sleepiness.

Practical Use Tips

Improve comfort during the first weeks

  • Take with a light meal if you feel nauseated.
  • Stand up slowly to reduce dizziness.
  • Stay hydrated (unless your clinician has advised fluid restriction).
  • Monitor your symptoms (headache, nausea, light-headedness, sleepiness).

Driving and machinery safety

Cabergoline can cause dizziness or drowsiness. Until you know how you respond:

  • Avoid driving if you feel sleepy or light-headed.
  • Use extra caution when operating machinery or working at heights.
  • Be careful with alcohol and other sedating medicines.

Track your weekly dose

  • Use a phone reminder for your weekly dosing day(s).
  • Keep a written record of dose changes if your regimen is adjusted.
  • If dose changes occur, confirm the new schedule clearly with your pharmacist.

Monitoring and follow-up

Your healthcare professional may request blood tests (commonly prolactin) and may schedule imaging or other evaluations depending on your diagnosis. Follow-up is essential to assess effectiveness and safety.


Alternative Options

Depending on your diagnosis and medical history, other treatments may be considered. Options may include:

  • Other dopamine agonists (for example, medicines in the same therapeutic class used for prolactin control).
  • Surgical approaches for selected pituitary lesions, where appropriate.
  • Radiotherapy in particular long-term or refractory situations.

The “best” alternative depends on the cause of prolactin elevation, tumour characteristics, and your response and tolerance to therapy. Ask your clinician about the options that fit your situation.


Australia: Market, Legal, and Guidance Context

In Australia, medicines like Dostinex/cabergoline are regulated under the country’s medicines framework. Availability and prescribing arrangements can vary by product classification and local healthcare pathways. Many patients obtain such medicines through community pharmacies after appropriate assessment.

Important: Healthcare decisions should be guided by qualified professionals who can review your history, diagnosis, current medicines, and relevant test results. Follow local health system advice for monitoring and safe use.

Recent guidance and monitoring considerations (general)

  • Dopamine-agonist awareness: Increased awareness of dopamine-agonist side effects, including sleepiness and impulse-control changes.
  • Cardiac monitoring: Because of long-term dopamine agonist exposure considerations in certain higher-dose contexts, clinicians may consider appropriate cardiac evaluation depending on risk factors and dosage.
  • Individualised titration: Dose titration strategies prioritise tolerability and symptom control.
  • Ongoing prolactin monitoring: Regular blood tests are commonly used to assess response.

Your healthcare provider will advise what monitoring is relevant for you.


Delivery and Availability (Online Pharmacy in Australia)

Online pharmacies in Australia typically provide a convenient way to purchase eligible medicines for eligible customers. Availability can depend on stock levels, packaging sizes, and supply chain factors.

  • Stock status: Many online listings show whether items are currently available.
  • Dispatch times: Delivery times vary depending on location (metropolitan vs regional/remote).
  • Packaging: Medicines are usually dispatched in original packaging to maintain integrity and labelling.
  • Delivery updates: Tracking may be provided depending on courier service.

If your medicine is unavailable at the time of purchase, the pharmacy may offer alternatives such as a comparable pack size or a restock notification (subject to availability). For urgent needs, contact customer service.


FAQ

1) What is Dostinex used for?

Dostinex (cabergoline) is commonly used to treat conditions where prolactin is too high, helping reduce prolactin levels and improve symptoms linked to hyperprolactinaemia.

2) How quickly will I feel better?

Some people notice improvement in symptoms within weeks, but complete response can take longer. Blood prolactin levels and symptom changes are often monitored over time to confirm effectiveness.

3) Does cabergoline need to be taken at the same time each week?

Yes—consistency is important. Many regimens are once or twice weekly on set day(s). If you must change timing, ask your pharmacist for guidance.

4) Can I take Dostinex with food?

It is often possible to take cabergoline with or without food. If you experience nausea, taking it with a light meal may help. Follow the instructions on your product information and your healthcare professional’s advice.

5) What should I do if I miss a dose?

Because cabergoline is often dosed weekly, the safest advice is to contact your pharmacist or healthcare professional for guidance on what to do next. Do not double the dose unless specifically instructed.

6) Can I drink alcohol while taking Dostinex?

Alcohol can worsen side effects like dizziness and sleepiness. If you choose to drink, do so cautiously and preferably avoid during the early phase of treatment or after dose increases. If you feel drowsy or light-headed, avoid driving and consider avoiding alcohol.

7) What medicines should I avoid or check for interactions?

It’s important to review all medicines with a pharmacist, especially drugs that affect blood pressure, cause drowsiness, or interact with dopamine pathways. Always provide a complete list of what you take, including supplements.

8) What are the warning signs that require urgent attention?

Seek urgent care if you faint, have severe dizziness, chest pain, shortness of breath, or signs of a serious allergic reaction. Contact a healthcare professional promptly for persistent severe symptoms.

9) Are there any long-term safety concerns?

Long-term dopamine agonist use may require monitoring depending on dose and your health history. Discuss any heart-related history or new symptoms with your healthcare provider.

10) What are practical tips to reduce side effects?

Stand up slowly, consider taking with food if nauseated, stay hydrated, and avoid alcohol until you know how you respond. Report side effects early—dose adjustments may help.


Need help deciding? If you have questions about how Dostinex may fit your situation, consult your healthcare professional. For advice about safe use and potential interactions, a pharmacist is a valuable resource.

Additional information

Dosage: No selection

0,25mg, 0,5mg

Package: No selection

8 pill, 12 pill, 16 pill, 20 pill, 32 pill